Filtros : "FCF004" Removidos: "lau" "vtu" Limpar

Filtros



Refine with date range


  • Source: Journal of Medicinal Chemistry. Unidade: FCF

    Subjects: MULHERES, QUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 13 nov. 2024. , 2024
    • APA

      Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097
    • NLM

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
    • Vancouver

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
  • Source: Archives of Health. Unidade: FCF

    Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, AGENTES ANTIMICROBIANOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HERRERIAS, Bruna Viggiano et al. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, v. 5, n. 1, p. 17-26, 2024Tradução . . Disponível em: https://dx.doi.org/10.46919/archv5n1-003. Acesso em: 13 nov. 2024.
    • APA

      Herrerias, B. V., Fernandes, R. C., Gonzaga, R. V., Balista, P. A., Dario, M. F., & Sobreira, F. (2024). Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, 5( 1), 17-26. doi:10.46919/archv5n1-003
    • NLM

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
    • Vancouver

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
  • Source: Natural Product Research. Unidade: FCF

    Subjects: CAROTENOIDES, URUCUM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 13 nov. 2024.
    • APA

      Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634
    • NLM

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
    • Vancouver

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
  • Source: Value in Health Regional Issues. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, REVISÃO SISTEMÁTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VISACRI, Marilia Berlofa et al. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, v. 43, p. 1-10 art. 100998, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vhri.2024.100998. Acesso em: 13 nov. 2024.
    • APA

      Visacri, M. B., Ribeiro, M. C., Komoda, D. S., Duarte, B. K. L., Corrêa, C. R. S., Maia, F. de O. M., & Alves, D. F. dos S. (2024). Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, 43, 1-10 art. 100998. doi:10.1016/j.vhri.2024.100998
    • NLM

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
    • Vancouver

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: MEDICAMENTO, NEOPLASIAS, FARMACOCINÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SUEYOSHI, Sophia Mikiko Oliveira et al. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, v. 663, p. 1-33 art. 124573, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ijpharm.2024.124573. Acesso em: 13 nov. 2024.
    • APA

      Sueyoshi, S. M. O., Silva, J. V. da, Guizze, F., & Giarolla, J. (2024). Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, 663, 1-33 art. 124573. doi:10.1016/j.ijpharm.2024.124573
    • NLM

      Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573
    • Vancouver

      Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573
  • Source: International Journal of Clinical Pharmacy. Unidade: FCF

    Subjects: SERVIÇOS FARMACÊUTICOS, MIELOMA MÚLTIPLO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PARK, Ji Won et al. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11096-024-01787-x. Acesso em: 13 nov. 2024.
    • APA

      Park, J. W., Pereira, T. T., Rotta, I., Lima, T. de M., Aguiar, P. M., & Visacri, M. B. (2024). A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy. doi:10.1007/s11096-024-01787-x
    • NLM

      Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
    • Vancouver

      Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
  • Source: Ageing Research Reviews. Unidade: FCF

    Subjects: DEGENERAÇÃO MACULAR, NANOPARTÍCULAS, CÉLULAS-TRONCO, ENSAIO CLÍNICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KUMBHAR, Popat et al. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, v. 98, p. 1-20 art. 102322, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102322. Acesso em: 13 nov. 2024.
    • APA

      Kumbhar, P., Kolekar, K., Vishwas, S., Shetti, P., Kumbar, V., Pinto, T. de J. A., et al. (2024). Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, 98, 1-20 art. 102322. doi:10.1016/j.arr.2024.102322
    • NLM

      Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
    • Vancouver

      Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
  • Source: Current Medicinal Chemistry. Unidades: FCF, IQ

    Subjects: FÁRMACOS, ANALGÉSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BORGES, Lara Gimenez et al. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673310050240821054652. Acesso em: 13 nov. 2024.
    • APA

      Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., & Parise Filho, R. (2024). Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry. doi:10.2174/0109298673310050240821054652
    • NLM

      Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
    • Vancouver

      Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
  • Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: FCF, EEL

    Subjects: ESCORPIÕES, VENENOS DE ORIGEM ANIMAL, DOENÇAS NEGLIGENCIADAS

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONTELLI, Ana P et al. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf. Acesso em: 13 nov. 2024.
    • APA

      Contelli, A. P., Ferraz, G. C., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., & Pedrozo, E. C. (2024). Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
    • NLM

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 nov. 13 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
    • Vancouver

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 nov. 13 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
  • Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF

    Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 13 nov. 2024.
    • APA

      Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907
    • NLM

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
    • Vancouver

      Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
  • Source: Experimental Dermatology. Unidade: FCF

    Subjects: ENZIMAS, DERMATOLOGIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NASCIMENTO, Natália Santos do et al. Enzymes for dermatological use. Experimental Dermatology, v. 33, p. 1-20, 2024Tradução . . Disponível em: https://dx.doi.org/10.1111/exd.15008. Acesso em: 13 nov. 2024.
    • APA

      Nascimento, N. S. do, Obreque, K. M. T., Oliveira, C. A. de, Cunha, J. R., Baby, A. R., Long, P. F., et al. (2024). Enzymes for dermatological use. Experimental Dermatology, 33, 1-20. doi:10.1111/exd.15008
    • NLM

      Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1111/exd.15008
    • Vancouver

      Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1111/exd.15008
  • Source: Cosmetics. Unidade: FCF

    Subjects: ARGILAS, COSMÉTICOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARRUF, Fernanda Daud et al. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, v. 11, p. 1-21, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cosmetics11010007. Acesso em: 13 nov. 2024.
    • APA

      Sarruf, F. D., Contreras, V. J. P., Martinez, R. M., Velasco, M. V. R., & Baby, A. R. (2024). The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, 11, 1-21. doi:10.3390/cosmetics11010007
    • NLM

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
    • Vancouver

      Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
  • Source: Scientia Pharmaceutica. Unidade: FCF

    Subjects: NANOPARTÍCULAS, GEOMETRIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VIEIRA, Aline Rocha et al. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, v. 92, n. 3, p. 1-17 art. 43, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/scipharm92030043. Acesso em: 13 nov. 2024.
    • APA

      Vieira, A. R., Oliveira, A. F., Pessoa, F. V. L. S., Miranda, B. N. M. de, & Baby, A. R. (2024). Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, 92( 3), 1-17 art. 43. doi:10.3390/scipharm92030043
    • NLM

      Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92( 3): 1-17 art. 43.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/scipharm92030043
    • Vancouver

      Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92( 3): 1-17 art. 43.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/scipharm92030043
  • Source: Estadão. Unidade: FCF

    Subjects: MEDICAMENTO, COVID-19

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PARISE FILHO, Roberto. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento. Tradução . Estadão, São Paulo, 2024. , v. 21 fe 2024Disponível em: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a. Acesso em: 13 nov. 2024.
    • APA

      Parise Filho, R. (2024). Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento. Estadão. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
    • NLM

      Parise Filho R. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento [Internet]. Estadão. 2024 ;21 fe 2024[citado 2024 nov. 13 ] Available from: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
    • Vancouver

      Parise Filho R. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento [Internet]. Estadão. 2024 ;21 fe 2024[citado 2024 nov. 13 ] Available from: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
  • Source: Proceedings. Conference titles: World Congress on Recent Advances in Nanotechnology/RAN. Unidades: EP, FCF

    Assunto: ORTOPEDIA

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIRIO, Adriana Cogo Malgueiro et al. Application of reactive RF magnetron sputtering in customized orthopedic implants. 2024, Anais.. Canada: Imperial College London Conference Center, 2024. Disponível em: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf. Acesso em: 13 nov. 2024.
    • APA

      Lirio, A. C. M., Arruda, A. C. S. de, Mansano, R. D., Pinto, A. F., & Pinto, T. de J. A. (2024). Application of reactive RF magnetron sputtering in customized orthopedic implants. In Proceedings. Canada: Imperial College London Conference Center. Recuperado de https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf
    • NLM

      Lirio ACM, Arruda ACS de, Mansano RD, Pinto AF, Pinto T de JA. Application of reactive RF magnetron sputtering in customized orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 nov. 13 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf
    • Vancouver

      Lirio ACM, Arruda ACS de, Mansano RD, Pinto AF, Pinto T de JA. Application of reactive RF magnetron sputtering in customized orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 nov. 13 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf
  • Source: Journal of Applied Electrochemistry. Unidade: FCF

    Subjects: ELETROQUÍMICA, VOLTAMETRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEIDA, Lígia Scandoglieri de et al. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, v. 54, p. 41-52, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10800-023-01945-5. Acesso em: 13 nov. 2024.
    • APA

      Almeida, L. S. de, Chiavassa, L. D., Brito, C. de L., Gatti, F. de M., Trossini, G. H. G., & La Scalea, M. A. (2024). Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, 54, 41-52. doi:10.1007/s10800-023-01945-5
    • NLM

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
    • Vancouver

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
  • Source: Ageing Research Reviews. Unidade: FCF

    Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 13 nov. 2024.
    • APA

      Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
    • NLM

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
    • Vancouver

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, BIODISPONIBILIDADE

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 13 nov. 2024.
    • APA

      Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141
    • NLM

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
    • Vancouver

      Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 13 nov. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: ACS Omega. Unidades: FCF, IQ

    Subjects: COMPOSTOS AROMÁTICOS, AMIDAS, LIPÍDEOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HORNINK, Milene Macedo et al. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction. ACS Omega, v. 9, n. 29, p. 31732–31744, 2024Tradução . . Disponível em: https://dx.doi.org/10.1021/acsomega.4c02645. Acesso em: 13 nov. 2024.
    • APA

      Hornink, M. M., Toledo, M. F. Z. J., Pimenta, D. C., Paschoalin, C., Silva, P. M., Figlino, G. E., et al. (2024). 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction. ACS Omega, 9( 29), 31732–31744. doi:10.1021/acsomega.4c02645
    • NLM

      Hornink MM, Toledo MFZJ, Pimenta DC, Paschoalin C, Silva PM, Figlino GE, Aguiar E, Cervi G, Ribeiro FWM, Correra TC, Ferry A, Stefani HA. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction [Internet]. ACS Omega. 2024 ; 9( 29): 31732–31744.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1021/acsomega.4c02645
    • Vancouver

      Hornink MM, Toledo MFZJ, Pimenta DC, Paschoalin C, Silva PM, Figlino GE, Aguiar E, Cervi G, Ribeiro FWM, Correra TC, Ferry A, Stefani HA. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction [Internet]. ACS Omega. 2024 ; 9( 29): 31732–31744.[citado 2024 nov. 13 ] Available from: https://dx.doi.org/10.1021/acsomega.4c02645

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024